2011
Barriers to antiretroviral adherence in HIV-positive patients receiving free medication in Kayunga, Uganda
Senkomago V, Guwatudde D, Breda M, Khoshnood K. Barriers to antiretroviral adherence in HIV-positive patients receiving free medication in Kayunga, Uganda. AIDS Care 2011, 23: 1246-1253. PMID: 21939403, DOI: 10.1080/09540121.2011.564112.Peer-Reviewed Original ResearchConceptsFree antiretroviral therapyHIV-positive patientsAntiretroviral therapyLack of accessPopulation of patientsDose timePill countAdherence estimatesAntiretroviral adherenceART clinicsAverage adherenceFree medicationMedicationsPatientsRural clinicsSocioeconomic barriersClinicLess adherentAdherenceSelf-reported estimatesRural districtsSelf-report methodsPillsMonthsSaharan AfricaFemale spouses of injection drug users in Pakistan: a bridge population of the HIV epidemic?
Ahmad S, Mehmood J, Awan A, Zafar S, Khoshnood K, Khan A. Female spouses of injection drug users in Pakistan: a bridge population of the HIV epidemic? Eastern Mediterranean Health Journal 2011, 17: 271-6. PMID: 22259883, DOI: 10.26719/2011.17.4.271.Peer-Reviewed Original ResearchConceptsInjection drug usersTherapeutic injectionsDrug usersMale injection drug usersCombination of diazepamSame health centerHIV transmission chainHIV epidemicInjection drugsHealth centersDrug useSex workPast monthDrugsHIVSexual practicesBridge populationFemale spousesInjectionTransmission chainSpousesDiazepamMonths
1993
Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut
Heimer R, Kaplan E, Khoshnood K, Jariwala B, Cadman E. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut. The American Journal Of Medicine 1993, 95: 214-220. PMID: 8356986, DOI: 10.1016/0002-9343(93)90263-o.Peer-Reviewed Original ResearchConceptsHIV-1 proviral DNANeedle exchange programsProviral DNANew Haven's needle exchange programNeedle exchangeHIV-1 prevalenceIntravenous drug usersNeedle exchange clientsDrug treatment programsPercentage of syringesDrug use habitsSyringe trackingDNA prevalenceNew HavenPolymerase chain reactionDrug treatmentDrug usersTreatment programPrevalenceChain reactionExchange programsSyringesMonthsProgram participantsFunded evaluation